FDA Approves AI-Powered Detection Device for Skin Cancers
The FDA has granted clearance for the first real-time, non-invasive skin cancer evaluation system .
Stay updated with breaking news from Dermasensor Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has granted clearance for the first real-time, non-invasive skin cancer evaluation system .
The first medical device powered by artificial intelligence and designed to help doctors catch skin cancer has been approved by the U.S. Food and Drug Administration. The first medical device powered by artificial intelligence and designed to help doctors catch skin cancer has been approved by the U.S. Food and Drug Administration.
FDA approves DermaSensor, the first AI-powered medical device which can detect all major types of skin cancer! Get the full details.
The US FDA has approved DermaSensor, a medical apparatus powered by artificial intelligence, which can detect the most prevalent skin cancers.
Discover the FDA-approved DermaSensor, an AI-powered device revolutionizing skin cancer detection for patients over 40.